# SAGILITY (NSE: SAGILITY) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/SAGILITY · Pivot · prices to 21 Oct 2026

SAGILITY (NSE: SAGILITY) closed at ₹43.19 on 21 Oct 2026. With a market capitalisation of ₹20,574 Cr, it ranks 353rd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Health Information Services.

At its last close the stock traded at 22.2× trailing earnings, against a return on equity of 9.6% in FY26. Over the past year the share price has fallen 5.2%. Its 52-week range is ₹35.83 (23 Mar 2026) to ₹57.89 (30 Oct 2025); the last close is 25.4% below the high. In Q1 FY27, the quarter ended 30 Jun 2026, revenue was ₹1,963 Cr (+27.6% year on year) and net profit ₹217 Cr (+45.9%), on a consolidated basis. Promoters held 50.95% of the company as of 30 Jun 2026; 100.00% of promoter shares were pledged.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹43.19 |
| Market cap | ₹20,574 Cr |
| P/E (trailing) | 22.2 |
| ROE | 9.6% (FY26) |
| ROCE | 12.8% (FY26) |
| Debt to equity | 0.11 |
| 52-week high | ₹57.89 (30 Oct 2025) |
| 52-week low | ₹35.83 (23 Mar 2026) |
| 1-year return | −5.2% |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q1 FY27 | ₹1,963 Cr | +27.6% | ₹217 Cr | +45.9% | ₹0.46 |
| Q4 FY26 | ₹2,024 Cr | +29.1% | ₹258 Cr | +41.2% | ₹0.56 |
| Q3 FY26 | ₹1,971 Cr | +35.7% | ₹268 Cr | +23.4% | ₹0.57 |
| Q2 FY26 | ₹1,659 Cr | +25.2% | ₹251 Cr | +113.8% | ₹0.53 |
| Q1 FY26 | ₹1,539 Cr | +25.8% | ₹149 Cr | +566.5% | ₹0.32 |
| Q4 FY25 | ₹1,568 Cr | +22.2% | ₹183 Cr | +127.6% | ₹0.39 |
| Q3 FY25 | ₹1,453 Cr | +15.3% | ₹217 Cr | +207.2% | ₹0.46 |
| Q2 FY25 | ₹1,325 Cr | +21.1% | ₹117 Cr | +235.6% | ₹0.25 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹5,570 Cr | ₹539 Cr |
| FY24 | ₹4,754 Cr | ₹228 Cr |
| FY23 | ₹4,218 Cr | ₹144 Cr |
| FY22 | ₹923 Cr | −₹5 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 50.95%
- Foreign institutions: 9.99%
- Domestic institutions: 21.42%
- Non-institutions: 17.64%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Procter Gamble](https://app.pivotnow.in/stock/PGHH) | ₹7,110.00 | ₹23,080 Cr | 26.9 | 62.3% |
| [Piramal Phytoca](https://app.pivotnow.in/stock/PIRPHYTO) | — | ₹21,083 Cr | — | — |
| [Indraprastha](https://app.pivotnow.in/stock/IGL) | ₹142.29 | ₹19,921 Cr | 12.9 | 27.0% |
| [Granules India](https://app.pivotnow.in/stock/GRANULES) | ₹802.85 | ₹19,894 Cr | 32.8 | 11.7% |
| [Cohance Lifesciences](https://app.pivotnow.in/stock/COHANCE) | ₹456.50 | ₹17,464 Cr | 97.8 | 15.8% |
| [Pfizer](https://app.pivotnow.in/stock/PFIZER) | ₹3,805.50 | ₹17,409 Cr | 24.1 | 17.2% |

## Questions and answers

### What is the share price of SAGILITY today?

SAGILITY (NSE: SAGILITY) last closed at ₹43.19 on 21 Oct 2026. Its 52-week high is ₹57.89 and its 52-week low is ₹35.83.

### What is the market cap of SAGILITY?

SAGILITY's market capitalisation is ₹20,574 Cr (₹20,574 Cr) at the 19 Oct 2026 close, ranking 353rd among the NSE companies Pivot tracks.

### What is the P/E ratio of SAGILITY?

SAGILITY trades at a trailing P/E of 22.2. The median P/E of the 5 closest Pharma & Healthcare peers by market cap is 26.9.

### What is the ROE and ROCE of SAGILITY?

Return on equity was 9.6% in FY26 and return on capital employed was 12.8% in FY26 (consolidated figures).

### Is SAGILITY a debt-free company?

No. SAGILITY's debt-to-equity ratio was 0.11 in FY26, with total debt of ₹381 Cr.

### What were SAGILITY's latest quarterly results?

For Q1 FY27 (quarter ended 30 Jun 2026), SAGILITY reported revenue of ₹1,963 Cr, +27.6% year on year, and net profit of ₹217 Cr, +45.9% year on year.

### How has SAGILITY stock performed over the last year?

SAGILITY's share price has fallen 5.2% over the past year, +5.9% over three months and −1.6% over one month, to the 19 Oct 2026 close.

### What is the shareholding pattern of SAGILITY?

As of 30 Jun 2026: promoters 50.95%, foreign institutions 9.99%, domestic institutions 21.42%, non-institutions 17.64%. 100.00% of promoter shares were pledged.

### Who are SAGILITY's competitors?

The listed Pharma & Healthcare companies closest to SAGILITY by market cap are Procter Gamble, Piramal Phytoca, Indraprastha, Granules India, Cohance Lifesciences and Pfizer.

### Is SAGILITY a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out SAGILITY's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on SAGILITY against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.